MSCAST- ام اس کست

In this episode we talked about geriatric MS with dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Here in the 33rd episode, we continue the 2022 journal highlights with Dr. Adibi thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Here in the 32th episode we go through 2022 journal highlights with Dr. Adibi thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

 in the 31st episode of MS Cast, we talked about Pregnancy and lactation in people diagnosed with MS together with Dr. Adibi thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 30a post-congress episodethank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 29thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 28thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 27in this episode we talk about breaking through and scalation of MS with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 26this episode talks about response monitoring tools of MS treatment with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 25this episode talks about new treatments and new drugs of MS treatment with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 24this episode talks about the Efficacy of MS treatments with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

Episode 23this episode talks about First line treatment of MS with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 22this episode is a Journal watch to review some article with Dr. Iman AdibiDOI of the first study: DOI of the second study:DOI of the first study:10.3340/jkns.2021.0195http://doi.org/10.3340/jkns.2021.0195DOI of the second study:10.1136/jnnp-2022-329227http://dx.doi.org/10.1136/jnnp-2022-329227DOI of the third study: 10.2217/nmt-2022-0009https://doi.org/10.2217/nmt-2022-000910.1177/13524585221102587:DOI of the fourth study https://doi.org/10.1177%2F13524585221102587DOI of the fifth study: 10.1093/braincomms/fcac181https://doi.org/10.1093/braincomms/fcac181DOI of the sixth study: 10.3390/biomedicines10071629https://doi.org/10.3390/biomedicines10071629DOI of the seventh study: 10.3390/brainsci12070954 https://doi.org/10.3390/brainsci12070954DOI of the eighth study: 10.1016/j.jcrc.2022.153985https://doi.org/10.1016/j.jcrc.2022.153985thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

In this episode, we are talking about recent topics of MS in EAN 2022 ___thank's Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 20 talks about the Epstein-Barr virus (EBV) and MS relationshipDOI of the study: 10.1212/WNL.0b013e318215286dhttps://doi.org/10.1212/WNL.0b013e318215286d thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 19this episode talks about Journal watchDOI of the first study: 10.1007/s00415-022-11205-9https://doi.org/10.1007/s00415-022-11205-9DOI of the second study:10.1007/s00415-022-11215-7https://doi.org/10.1007/s00415-022-11215-7DOI of the third study: 10.1016/j.msard.2021.103437https://doi.org/10.1016/j.msard.2021.103437DOI of the fourth study:10.3389/fimmu.2022.834644https://doi.org/10.3389/fimmu.2022.834644DOI of the fifth study: 10.1016/j.msard.2022.103638https://doi.org/10.1016/j.msard.2022.103638DOI of the sixth study: 10.1016/j.msard.2022.103760https://doi.org/10.1016/j.msard.2022.103760thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 18 talks about treatment optimizationDOI of first study:https://doi.org/10.1007/s00415-020-10074-4DOI of second study:http://dx.doi.org/10.1136/jnnp.2008.145805thank's Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 17This episode talksabout Patient profile & prognostication in Multiple SclerosisDOI of study:10.1016/j.msard.2021.102854https://www.sciencedirect.com/science/article/pii/S2211034821001206Thanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 16This episode talksabout Pregnancy Management in Multiple Sclerosis and Other Demyelinating DiseasesDOI of study:10.1212/CON.0000000000001108https://journals.lww.com/continuum/Abstract/2022/02000/Pregnancy_Management_in_Multiple_Sclerosis_and.4.aspxThanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/

episode 15The second episode talksabout Canadian MS Working GroupUpdated Recommendationsand switching medication positionDOI of study:10.1017/S0317167100014244https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/treatment-optimization-in-ms-canadian-ms-working-group-updated-recommendations/F7CA82BA3ADDD05DB9EF45D60802DE01Thanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/